Keywords: Inlammatory bowel diseases, IBD, Drug market, Visiongain

Global inflammatory bowel drug market will reach $6.9 billion in 2015, says Visiongain

Article | 26 July 2011

Worldwide drug revenues for treating inflammatory bowel diseases (IBD) will reach $6.9 billion in 2015. The IBD drug market generated revenues of $5 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in